State of Wisconsin Investment Board
PRLD icon

State of Wisconsin Investment Board’s Prelude Therapeutics PRLD Stock Holding History

State of Wisconsin Investment Board’s Portfolio PRLD Stock Details PRLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18,700
Closed -$71.2K – 2347
2024
Q2 		$71.2K Sell
18,700
-900
-5% -$3.66K ﹤0.01% 2237
2024
Q1 		$92.9K Sell
19,600
-5,200
-21% -$20.2K ﹤0.01% 2134
2023
Q4 		$106K Sell
24,800
-36,800
-60% -$112K ﹤0.01% 2267
2023
Q3 		$190K Sell
61,600
-16,700
-21% -$62.7K ﹤0.01% 2258
2023
Q2 		$352K Sell
78,300
-11,900
-13% -$71.1K ﹤0.01% 1944
2023
Q1 		$514K Sell
90,200
-10,200
-10% -$62.2K ﹤0.01% 1864
2022
Q4 		$606K Sell
100,400
-8,700
-8% -$55.8K ﹤0.01% 1813
2022
Q3 		$721K Sell
109,100
-18,100
-14% -$122K ﹤0.01% 1742
2022
Q2 		$664K Buy
127,200
+52,700
+71% +$268K ﹤0.01% 1926
2022
Q1 		$514K Buy
74,500
+61,200
+460% +$560K ﹤0.01% 1853
2021
Q4 		$166K Hold
13,300
– – ﹤0.01% 2104
2021
Q3 		$416K Hold
13,300
– – ﹤0.01% 1739
2021
Q2 		$381K Hold
13,300
– – ﹤0.01% 1766
2021
Q1 		$576K Buy
+13,300
New +$882K ﹤0.01% 1553

Other funds holding PRLD

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State of Wisconsin Investment Board's PRLD Position: Q3 2024 in Review

State of Wisconsin Investment Board sold out of Prelude Therapeutics (PRLD) in Q3 2024, closing a stake of 18,700 shares — an estimated $71.2K sold.

State of Wisconsin Investment Board first reported a position in PRLD in Q1 2021 and held it in 14 quarters. The position peaked at $721K in Q3 2022. 70 funds tracked by Wall St. Rank hold PRLD as of Q3 2024.

  • State of Wisconsin Investment Board reported no remaining Prelude Therapeutics position as of Q3 2024 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 18,700 Prelude Therapeutics shares in Q3 2024, an estimated $71.2K.
  • State of Wisconsin Investment Board first reported a position in Prelude Therapeutics in Q1 2021 and held it in 14 quarters.
  • State of Wisconsin Investment Board's Prelude Therapeutics position peaked at $721K in Q3 2022.
  • 70 funds tracked by Wall St. Rank held Prelude Therapeutics as of Q3 2024.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2024, filed 14 Nov 2024.